$HRGN
Harvard Apparatus Regenerative Technology Inc

2015 Q3 Form 10-Q Financial Statement

#000114420415065441 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q4 2014 Q3
Revenue $37.00K $45.00K $2.000K
YoY Change 1750.0% 104.55%
Cost Of Revenue $18.00K $23.00K $1.000K
YoY Change 1700.0% 109.09%
Gross Profit $19.00K $22.00K $1.000K
YoY Change 1800.0% 100.0%
Gross Profit Margin 51.35% 48.89% 50.0%
Selling, General & Admin $1.042M $1.580M $1.276M
YoY Change -18.34% 0.0% 27.35%
% of Gross Profit 5484.21% 7181.82% 127600.0%
Research & Development $1.269M $1.290M $1.401M
YoY Change -9.42% 19.44% 32.42%
% of Gross Profit 6678.95% 5863.64% 140100.0%
Depreciation & Amortization $120.0K $100.0K $110.0K
YoY Change 9.09% 150.0% 175.0%
% of Gross Profit 631.58% 454.55% 11000.0%
Operating Expenses $2.311M $2.864M $2.677M
YoY Change -13.67% 7.71% 29.95%
Operating Profit -$2.292M -$2.842M -$2.676M
YoY Change -14.35% 7.33% 29.9%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$4.000K
YoY Change -100.0%
Pretax Income -$2.292M -$2.842M -$2.680M
YoY Change -14.48% 7.33% 30.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.292M -$2.842M -$2.680M
YoY Change -14.48% 7.33% 30.1%
Net Earnings / Revenue -6194.59% -6315.56% -134000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.817M -$7.282M -$6.872M
COMMON SHARES
Basic Shares Outstanding 7.857M shares 7.847M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.200M $5.270M $7.720M
YoY Change 6.22% -62.38%
Cash & Equivalents $8.198M $5.272M $7.722M
Short-Term Investments
Other Short-Term Assets $80.00K $30.00K
YoY Change 166.67% 0.0%
Inventory $140.0K $207.0K $160.0K
Prepaid Expenses $317.0K $117.0K
Receivables $59.00K $5.000K $30.00K
Other Receivables $0.00 $20.00K $0.00
Total Short-Term Assets $8.480M $5.828M $8.058M
YoY Change 5.24% -59.78% 24318.18%
LONG-TERM ASSETS
Property, Plant & Equipment $1.202M $1.376M $1.354M
YoY Change -11.23% 139.3% 194.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.202M $1.376M $1.354M
YoY Change -11.23% 139.3% 194.35%
TOTAL ASSETS
Total Short-Term Assets $8.480M $5.828M $8.058M
Total Long-Term Assets $1.202M $1.376M $1.354M
Total Assets $9.685M $7.204M $9.412M
YoY Change 2.9% -52.18% 1809.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K $370.0K $254.0K
YoY Change -13.39% 51.64% 101.59%
Accrued Expenses $110.0K $320.0K $430.0K
YoY Change -74.42% 100.0% 72.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $331.0K $710.0K $716.0K
YoY Change -53.77% 43.43% 88.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $331.0K $710.0K $716.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $331.0K $710.0K $716.0K
YoY Change -53.77% 43.43% 88.92%
SHAREHOLDERS EQUITY
Retained Earnings -$22.45M -$13.04M -$10.19M
YoY Change 120.24% 560.33% -45.1%
Common Stock $127.0K $79.00K $79.00K
YoY Change 60.76% 2.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.354M $6.494M $8.696M
YoY Change
Total Liabilities & Shareholders Equity $9.685M $7.204M $9.412M
YoY Change 2.9% -52.18% 1820.82%

Cashflow Statement

Concept 2015 Q3 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$2.292M -$2.842M -$2.680M
YoY Change -14.48% 7.33% 30.1%
Depreciation, Depletion And Amortization $120.0K $100.0K $110.0K
YoY Change 9.09% 150.0% 175.0%
Cash From Operating Activities -$1.850M -$2.320M -$1.860M
YoY Change -0.54% 11.0% 5.08%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K -$130.0K -$530.0K
YoY Change -69.81% -13.33% 430.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$160.0K -$130.0K -$530.0K
YoY Change -69.81% -13.33% 430.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K 0.000 60.00K
YoY Change 33.33% -100.0% -96.77%
NET CHANGE
Cash From Operating Activities -1.850M -2.320M -1.860M
Cash From Investing Activities -160.0K -130.0K -530.0K
Cash From Financing Activities 80.00K 0.000 60.00K
Net Change In Cash -1.930M -2.450M -2.330M
YoY Change -17.17% -117.49% 23200.0%
FREE CASH FLOW
Cash From Operating Activities -$1.850M -$2.320M -$1.860M
Capital Expenditures -$160.0K -$130.0K -$530.0K
Free Cash Flow -$1.690M -$2.190M -$1.330M
YoY Change 27.07% 12.89% -20.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1199000 USD
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
27000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
207000 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
317000 USD
CY2014Q3 us-gaap Revenues
Revenues
2000 USD
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
18000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
1000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
19000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1269000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1401000 USD
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
956000 USD
CY2015Q3 us-gaap Assets
Assets
9685000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
220000 USD
CY2015Q3 us-gaap Revenues
Revenues
37000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
5828000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3832000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3504000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
127000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Operating Expenses
OperatingExpenses
8238000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8215000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8219000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10395000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
2311000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2677000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2292000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2676000 USD
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7851000 shares
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2292000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2683000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2680000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Revenues
Revenues
110000 USD
us-gaap Revenues
Revenues
48000 USD
us-gaap Cost Of Revenue
CostOfRevenue
55000 USD
us-gaap Cost Of Revenue
CostOfRevenue
25000 USD
us-gaap Gross Profit
GrossProfit
55000 USD
us-gaap Gross Profit
GrossProfit
23000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
276000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
241000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5686000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4165000 USD
us-gaap Operating Expenses
OperatingExpenses
9466000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9411000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7809000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9422000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8219000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9414000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8219000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3612000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1926000 USD
us-gaap Depreciation
Depreciation
347000 USD
us-gaap Depreciation
Depreciation
256000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-27000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-19000 USD
CY2015Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1202000 USD
CY2015Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2015Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
111000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
331000 USD
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2015Q3 us-gaap Liabilities
Liabilities
331000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22449000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13035000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30453000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19449000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
9354000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6494000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9685000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7204000 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
1230000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-2292000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2680000 USD
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11974000 shares
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-9414000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-150000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-16000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-58000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-212000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
269000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5562000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5671000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
175000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1033000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-175000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1033000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3314000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
418000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8671000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2292000 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-63000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
119000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8198000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7722000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
418000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-8000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2926000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6286000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5272000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14008000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5357000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
54000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1100000 USD
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9700000 USD
CY2015Q1 hart Proceeds From Issuance Of Stock To Underwriters
ProceedsFromIssuanceOfStockToUnderwriters
8600000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-235000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-274000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
959000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
611000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12652075 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12652075 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7856607 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7856607 shares
CY2013Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1202000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1376000 USD
hart Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y

Files In Submission

Name View Source Status
0001144204-15-065441-index-headers.html Edgar Link pending
0001144204-15-065441-index.html Edgar Link pending
0001144204-15-065441.txt Edgar Link pending
0001144204-15-065441-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hart-20150930.xml Edgar Link completed
hart-20150930.xsd Edgar Link pending
hart-20150930_cal.xml Edgar Link unprocessable
hart-20150930_def.xml Edgar Link unprocessable
hart-20150930_lab.xml Edgar Link unprocessable
hart-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v424270_10q.htm Edgar Link pending
v424270_ex31-1.htm Edgar Link pending
v424270_ex31-2.htm Edgar Link pending
v424270_ex32-1.htm Edgar Link pending
v424270_ex32-2.htm Edgar Link pending